WhenEnterobacter cloacae, Citrobacter freundii, and Proteus vulgaris were treated with piperacillin (PIPC) in combination with tazobactam (TAZ), the in vitro frequency of emergence of resistant strains (/Mactamase producing mutants) was lower than with PIPC or ceftazidime (CAZ) treated bacteria. In a mouse intraperitoneal infection model caused by E. cloacae, /Mactamase derepressed mutants were detected following therapy with PIPC or CAZ, although no derepressed mutants were detected after treatment with PIPCin combination with TAZ.This suppression of the selection of derepressed mutants, which produce large amounts of /Mactamases, by the combination of TAZand PIPCsuggests that the combination delays the increase of resistant mutants compared with PIPC alone.
1) Hydrolysis of drugs by /Mactamase produced by the bacteria, 2) changes in the affinity to penicillinbinding proteins, and 3) reduction in the permeability of the bacterial outer membrane to the drugs are considered to be primary mechanisms of resistance of bacteria to /Mactams. Among them, hydrolysis of antibiotics by /Mactamase is considered to be the main cause of resistance to /Mactams, because /Mactamase has been frequently detected from many clinical isolates1}.
jS-Lactamases
are classified into penicillinases (PCases), cephalosporinases (CEPases), and oxyiminocephalosporinases (CXases) according to their substrate profile2). Most PCases are encoded on transposons and plasmids, primarily inhibit penicillins, which are their substrates, and produce resistance to ampicillin and piperacillin (PIPC). CEPases and CXases are encoded on the chromosome,and are major causes of resistance of Gram-negative rods to cephalosporins, which are their substrates3). As countermeasures against resistance to /Mactams, antibiotics which are stable to /Mactamases have been developed, as well as combination of/Mactams with /Mactamase inhibitors to increase their antibacterial activity. Recently, however, bacterial strains resistant even to /Mactams with increased stability against /?-lactamases, including third generation cephalosporins, have been reported4). The resistance of such bacteria to 1027 these /Mactams is considered to be caused partly by an increase of CEPaseactivity as a result of the change in the manner of CEPaseproduction from inducible to constitutive5'6*. Such resistant bacteria, which are called derepressed mutants (drd mutants), are easily selected in vitro by treatment with /Mactams. Therefore, there exists the possibility to increase the emergence of such resistant bacteria to /Mactam antibiotics in clinical practice6*. After the bacteria were incubated in STB at 37°C overnight, a 5-to 10-fold dilution of the overnight culture was spread on SDAcontaining 4 to 32 times the MIC of drugs, and colonies were counted after 48-hour incubation at 37°C. Then, colonies were selected randomly and subcultured in drug free-SDA at 37°C, and the antibiotic susceptibility was evaluated.
Measurement of the /?-Lactamase Activity Bacteria were incubated overnight in STB, the culture was diluted 20-fold with fresh STB, and incubated with shaking at 37°C for about 4 hours. Some bacterial strains were incubated with shaking at 37°C for about 2 hours and then CFXwas added and incubated for 2 hours to induce /Mactamase. Bacteria were harvested by centrifugation at 1 ,500 x g for 10 minutes, washed twice with 0.05 m phosphate buffer (pH 7), and suspended with the same bu|fer. This bacterial suspension was sonicated in ice and then centrifuged at 15,000 x g for 10 minutes with cooling, and the /Mactamase activity in the supernatant was measured by UV method8). CET (100/im) was used as the substrate.
Evaluation of the Frequency of the Emergence of j8-Lactamase Derepressed Mutants in Intraperitoneally Infected Mice
Male ddY mice aged 4 weeks were used in groups of 3. Suspensions of the test bacteria were inoculated intraperitoneally at about 108 CFU/mouse, and the drugs were administered subcutaneously at l O mg/mouse 5 times at intervals of 1 hour. Seven hours after inoculation, the bacteria in the peritoneal cavity were recovered by lavage with saline, and then diluted with saline, spread on nutrient agar (NA, Difco) for a target number of 100~200 colonies, and incubated overnight at 37°C. Iodine-starch agar (3.2mM I2, 24mM KI, 0.4% starch, 0.8% agar; 10ml) containing 2mg/ml CET was layered over the agar plates on which the colonies had grown, and colonies that showed decoloration after 30~120minutes were regarded as those of /Mactamase derepressed mutants. Next, drug sensitivity of these strains was examined to evaluate their resistance. SEPT. 1995 
Results

Effects of /?-Lactamase Inhibitors on the
Emergence of Resistant Mutants To study the effects of /Mactamase inhibitors on the emergence of resistant mutants, PIPC-sensitive E. cloacae strain 40001 was treated with PIPC alone or in combination with 10 jug/ml ofa /Mactamase inhibitor, namely TAZ, CVA, or SBT, and the frequency of the emergence of resistant colonies wascompared. As shown in Fig. 1 , the frequency of the emergence of resistant colonies decreased with the increase in the concentration of PIPC, but resistant colonies emerged with a high selection frequency of almost 10~6 at 4 times the MICand were observed even at 16 times the MIC. WhenTAZwas added, however, no resistant colonies were observed at all PIPC concentrations examined. On the other hand, when PIPC was added with CVAor SBT, the selection frequency of resistant colonies was 10"6-10"7 at 4 times the MIC and 10"7-10"8 at 8 times the MIC. WhenCVAwas added, resistant colonies were observed even at a PIPC concentration of 16 times the MIC. Resistant colonies thus selected were subcultured in drug free-SDA, and their drug sensitivity was evaluated. MICof PIPC was over 12.5/ig/ml regardless of the drugs used for their selection, indicating resistance to PIPC; bacteria selected with 16 times the MIC ofPIPC included those for which the MIC ofPIPC was over 100^g/ml indicating higher resistance to PIPC.
In 0"9 at 8 times the MICor over, and with CAZ, resistant colonies were observed at a frequency of 10"7 even at 32 times the MIC in 40001 strain. In E. cloacae 40012, few resistant colonies were noted after treatment with TAZ/PIPC, PIPC+TAZ, or PIPC alone, but resistant colonies were observed after treatment with CAZeven at 32 times the MICas with strain 40001. Many resistant 3.7X10"7 1.3X10"7 4.2X10"6 5.0X10"7 1.3X10"8 N.D.
2.6X10"6 6.8X10'8 N.D.
N.D. 2.7X10"6 2.5X10-6 2.1X10"6 2.0X10"7 4.2X10"6 3.6X10'8 3.6X10"6 3.8X10"6 * Inoculum size ; 105 CFU/spot. N. D. = Not detectable with the method employed.
colonies were observed in E. cloacae 40029 with all drugs, but the frequency of their emergence was lower after treatment with PIPC +TAZand TAZ/PIPC than after treatment with PIPC alone. CAZtreatment resulted in the greatest numberof resistant colonies. In C. freundii, fewer resistant colonies were observed than in E. cloacae with all drugs, and few resistant colonies were observed in most strains after treatment Units/mg protein (substrate; 100 /^m cephalotin). Cefoxitin concentration (10 /ig/ml for, E. cloacae 1 /ig/ml for C. freundii). Tazobactamwas used at fixed concentration of 10/ig/mL with TAZ/PIPC or PIPC+TAZ. However, resistant colonies appeared at 10 " 7~10~8 after the treatment with CAZ.
With P. vulgaris, no resistant colonies emerged after treatment with TAZ/PIPC or PIPC+TAZat all concentrations, but resistant colonies were noted in some strains at a frequency of 10"8 after treatment with PIPC or CAZat 4 or 8 times the MIC. reduced 2~4, 16, and 8 times, respectively, compared with that of parent strains. The /Mactamase activity of resistant strains also increased compared with the parent strains, though less remarkably than in E. cloacae, and there was only slight induction of enzyme production by the addition of CFX.From these findings, we conclude that drd mutants were selected in the above process.
In Vitro Evaluation of Antibiotic Susceptibility and /?-Lactamase Production of Resistant Mutants
In Vivo Evaluation of the Emergence of Resistant Mutants Table 5 shows resistant bacteria observed in a mouse intraperitoneal infection model with E. cloacae 40001 after treatment with TAZ/PIPC, PIPC, and CAZ.
No bacterial strains that produced high levels of /Mactamase were observed in the 18,580 colonies recovered from the TAZ/PIPC group. Ten colonies of /?-lactamase derepressed strains were detected in the 3,209 colonies recovered (selection frequency was about 10~3) in the PIPC group, and 4 of the ll,746 colonies (about 10~4) recovered in the CAZ group were /J-lactamase derepressed mutants. Susceptibility and /Mactamase activity were measured in bacterial strains selected in the PIPC and CAZ groups. MIC of TAZ/PIPC was 50-100/ig/ml, and those of PIPC and CAZwere 100/xg/ml or over, indicating that these strains were moreresistant than their parent strains. /?-Lactamase production was also increased ( Gram-negative bacteria and have achieved remarkable results in the treatment of infections. However, there appeared a few novel problems. The first is the unusual increase in the incidence of methicillin-resistant Staphylococcus aureus (MRSA)and the increase in the frequency of isolation of streptococci9). These problems are considered to be results of bacterial selection through the increased use of third generation cephalosporins, which have no great effects on Gram-positive bacteria. The second is the appearance of Gram-negative bacteria which are resistant to third generation cephalosporins40.
The cause of this resistance is frequently /Mactamase SEPT. 1995 production. Changes in the substrate specificity due to point mutation ofTEMtype and SHVtype PCase genes and widening of the substrate profile (extended-spectrum /Mactamase) have been reported10). On the other hand, resistance to /Mactams due to changes in the manner of enzyme production has been reported in E. cloacae, C. freundii, and Pseudomonas aeruginosa, which produce chromosomally mediated /Mactamase5>6). The original inducible /Mactamase production of these bacteria is changed to constitutive production, and results in a large amount of /Mactamase being produced, with resistance to a wide spectrum of antibiotics including third generation cephalosporins, which used to be considered stable. These bacteria are so-called derepressed mutants. The basis for this emerging resistance seems to be that /Mactamaseproducing populations always contain a few derepressed mutants. Usually these mutants occur at a frequency of 10~6~10~7, but they may be more frequent in some Gram-negative bacterial strains. When these heterogenous populations are challenged with TAZ/PIPC, even the mutant cell fails to manufacture jS-lactamase with TAZ and are killed by the PIPC. The derepressed variants, however, produced the high amountof enzyme, and so can protect themself from PIPC.
As observed above, resistance to /Mactams is closely related to /Mactamase, but its cause is being diversified as exemplified by the advent of extended-spectrum /?-lactamase and derepressed mutants.^-Lactamase inhibitors are considered to be useful, because they inhibit extended-spectrum /Mactamases and, as suggested by this study, maydelay the increase in resistant strains called derepressed mutants. Moreover, next generation cephalosporins that are effective against a wider spectrum of bacteria than third generation cephalosporins and are stable against /Mactamase have been developed and recently put into clinical use16)17). However, as experienced with third generation cephalosporins, the use of these drugs is expected to cause further diversification of /Mactam resistance and the development of new resistant bacteria in increased numbers. Therefore, from the laboratory viewpoint, greater attention to the appropriate use of antibacterial agents is considered to be all the more important.
